Urinary Chloride-to-Creatinine Ratio as an Early Predictor of Diuretic Resistance in Acute Heart Failure
DOI:
https://doi.org/10.53350/pjmhs02026208.5Keywords:
acute heart failure; chloride; creatinine; decongestion; diuretic resistance; furosemide; urinary biomarkersAbstract
Background: Diuretic resistance is an important issue in the management of acute heart failure, as it is associated with slow decongestive response and high likelihood of ongoing fluid retention, renal failure and longer hospital stays. The aim of this study was to assess the usefulness of the urinary chloride to creatinine ratio as an early predictor for inadequate diuretic response.
Methods: This is a prospective, observational study of 110 adults hospitalized at Mayo Hospital Lahore with acute heart failure from April 2025 to April 2026. Spot urine was done two hours following the first dose of intravenous Furosemide. Diuretic resistance was considered to be low urine output on 24-hour basis, poor weight loss and intensification of diuretic therapy. ROC analysis and multivariable logistic regression were undertaken.
Results: Diuretic resistance occurred in 35 patients (31.8%). The median urinary chloride to creatinine ratio was significantly lower in resistant compared to responsive patients (56 [38-72] vs 118 [86-156] mmol/g, p<0.001). A cut-off of < 72 mmol/g was shown to have 82.9% sensitivity, 78.7% specificity, and an area under the curve of 0.86 for predicting resistance. A ratio <72 mmol/g was independently associated with resistance after the adjustment (adjusted odds ratio 6.18; 95% confidence interval 2.43–15.69; p<0.001). Resistant patients were also less likely to have high urine output, less net fluid loss, more worsening renal function, persistent congestion, and shorter hospital stay. After adjustment for kidney function, systolic blood pressure, chronic use of a loop diuretic, serum chloride and sex, the association was still present, suggesting that it is independently predictive in routine clinical practice settings.
Conclusion: Urinary chloride to creatinine ratio is a fast, simple, and clinically helpful method of rapid assessment of early diuretic resistance in acute heart failure.
References
Fujimoto Y, Kitai T, Nasu T, Matsumoto S, Naruse Y, Hioki H, et al. Diuretic resistance measured by sodium excretion and urine output in acute heart failure: the DIURESIS-AHF study. J Cardiol. 2026;87(2):167–173. doi:10.1016/j.jjcc.2025.06.018.
Guzik M, Zymliński R, Ponikowski P, Biegus J. Urine chloride trajectory and relationship with diuretic response in acute heart failure. ESC Heart Fail. 2025;12(1):133–141. doi:10.1002/ehf2.15054.
Ramírez-Sánchez P, Falcón-Aguirre A, Tepayotl-Aponte A, Mendoza-Zavala GH, Olmos-Dominguez L, Chavez-Mendoza A, et al. External validation of the natriuretic response prediction equation to discriminate diuretic response in heart failure. ESC Heart Fail. 2025;12(1):668–671. doi:10.1002/ehf2.14801.
Khorramshahi Bayat M, Chan W, Hay K, McKenzie S, Adhikari P, Fincher G, et al. Spot urinary sodium-guided titration of intravenous diuretic therapy in acute heart failure: a pilot randomized controlled trial. Eur Heart J Qual Care Clin Outcomes. 2025;11(1):97–104. doi:10.1093/ehjqcco/qcae028.
Nawrocka-Millward S, Biegus J, Fudim M, Guzik M, Iwanek G, Ponikowski P, et al. The role of urine chloride in acute heart failure. Sci Rep. 2024;14(1):14100. doi:10.1038/s41598-024-64747-5.
Iwanek G, Guzik M, Zymliński R, Fudim M, Ponikowski P, Biegus J. Spot urine sodium-to-creatinine ratio surpasses sodium in identifying poor diuretic response in acute heart failure. ESC Heart Fail. 2024;11(5):3438–3442. doi:10.1002/ehf2.14883.
Van den Eynde J, Martens P, Dauw J, Nijst P, Meekers E, Ter Maaten JM, et al. Serum chloride and the response to acetazolamide in patients with acute heart failure and volume overload: a post hoc analysis from the ADVOR trial. Circ Heart Fail. 2024;17(10):e011749. doi:10.1161/CIRCHEARTFAILURE.123.011749.
Dauw J, Charaya K, Lelonek M, Zegri-Reiriz I, Nasr S, Paredes-Paucar CP, et al. Protocolized natriuresis-guided decongestion improves diuretic response: the multicenter ENACT-HF study. Circ Heart Fail. 2024;17(1):e011105. doi:10.1161/CIRCHEARTFAILURE.123.011105.
Damman K, Beldhuis IE, van der Meer P, Krikken JA, Coster JE, Nieuwland W, et al. Renal function and natriuresis-guided diuretic therapy: a pre-specified analysis from the PUSH-AHF trial. Eur J Heart Fail. 2024;26(6):1347–1357. doi:10.1002/ejhf.3228.
Ter Maaten JM, Beldhuis IE, van der Meer P, Krikken JA, Postmus D, Coster JE, et al. Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial. Nat Med. 2023;29(10):2625–2632. doi:10.1038/s41591-023-02532-z.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2023 focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627–3639. doi:10.1093/eurheartj/ehad195.
Trullàs JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Sánchez-Marteles M, Conde-Martel A, et al. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J. 2023;44(5):411–421. doi:10.1093/eurheartj/ehac689.
Cox ZL, Siddiqi HK, Stevenson LW, Bales B, Han JH, Hart K, et al. Randomized controlled trial of urine chemistry-guided acute heart failure treatment (ESCALATE): rationale and design. Am Heart J. 2023;265:121–131. doi:10.1016/j.ahj.2023.07.014.
Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, et al. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med. 2022;387(13):1185–1195. doi:10.1056/NEJMoa2203094.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. Circulation. 2022;145(18):e895–e1032. doi:10.1161/CIR.0000000000001063.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368.
Biegus J, Zymliński R, Fudim M, Testani J, Sokolski M, Marciniak D, et al. Spot urine sodium in acute heart failure: differences in prognostic value on admission and discharge. ESC Heart Fail. 2021;8(4):2597–2602. doi:10.1002/ehf2.13372.
Biegus J, Zymliński R, Testani J, Marciniak D, Zdanowicz A, Jankowska EA, et al. Renal profiling based on estimated glomerular filtration rate and spot urine sodium identifies high-risk acute heart failure patients. Eur J Heart Fail. 2021;23(5):729–739. doi:10.1002/ejhf.2053.
Biegus J, Zymliński R, Sokolski M, Todd J, Cotter G, Metra M, et al. Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure. Eur J Heart Fail. 2019;21(5):624–633. doi:10.1002/ejhf.1428.
Hodson DZ, Griffin M, Mahoney D, Raghavendra P, Ahmad T, Turner J, et al. Natriuretic response is highly variable and associated with 6-month survival: insights from the ROSE-AHF trial. JACC Heart Fail. 2019;7(5):383–391. doi:10.1016/j.jchf.2019.01.007.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2026 Benazeer Mikrani, Muhammad Mohsin Mahmood, Aneela Jumadin, Muhammad Mansoor Sarwer, Haris Mahmood, Muhammad Asif Farooqi, Siddiqa Akram, Minahil Shahzad, Muhammad Ali Iftkhar

This work is licensed under a Creative Commons Attribution 4.0 International License.
